Artificial intelligence for prostate cancer diagnostics

2025-09-02 09:31:47 英文原文

作者：Rannikko, Antti S.

Prostate MRI has emerged as a way to improve accuracy in prostate cancer diagnostics. However, the subjectivity of assessments remains a challenge. New research shows that AI can help in this task and serve as a tool to improve MRI-based prediction of prostate cancer aggressiveness.

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

27,99 € / 30 days

cancel any time

Subscribe to this journal

Receive 12 digital issues and online access to articles

111,21 € per year

only 9,27 € per issue

Buy this article

Purchase on SpringerLink
Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

References

James, N. D. et al. Lancet 403, 1683–1722 (2024).
PubMed PubMed Central Google Scholar
Schröder, F. H. et al. N. Engl. J. Med. 360, 1320–1328 (2009).
PubMed Google Scholar
Bratt, O. et al. BMJ Oncol. 2, e000039 (2023).
PubMed PubMed Central Google Scholar
Ahmed, H. U. et al. Lancet 389, 815–822 (2017).
PubMed Google Scholar
Kasivisvanathan, V. et al. N. Engl. J. Med. 378, 1767–1777 (2018).
PubMed PubMed Central Google Scholar
Shadbahr, T. et al. Preprint at medRxiv https://doi.org/10.1101/2025.03.20.25324337 (2025).
Auvinen, A. et al. JAMA 331, 1452–1459 (2024).
CAS PubMed PubMed Central Google Scholar
Eklund, M. et al. N. Engl. J. Med. 385, 908–920 (2021).
PubMed Google Scholar
Hugosson, J. et al. N. Engl. J. Med. 387, 2126–2137 (2022).
CAS PubMed PubMed Central Google Scholar
Eastham, J. A. et al. J. Urol. 208, 10–18 (2022).
PubMed Google Scholar
Saha, A. et al. Lancet Oncol. https://doi.org/10.1016/S1470-2045(24)00220-1 (2024).
Article PubMed PubMed Central Google Scholar
Shao, L. et al. Nat. Cancer https://doi.org/10.1038/s43018-025-01041-x (2025).
Article Google Scholar

Download references

Author information

Authors and Affiliations

Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Antti S. Rannikko
Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Antti S. Rannikko
iCAN-Digital Precision Cancer Medicine Flagship, Helsinki, Finland
Antti S. Rannikko

Corresponding author

Correspondence to Antti S. Rannikko.

Ethics declarations

Competing interests

A.R. reports being an advisory board member for Bayer, Johnson & Johnson Innovative Medicine (formerly Janssen) and Orion Pharma; holding a leadership role in the Orion Research Foundation (board chair); and being a member of the board for the Ida Montin Research Foundation

About this article

Cite this article

Rannikko, A.S. Artificial intelligence for prostate cancer diagnostics. Nat Cancer (2025). https://doi.org/10.1038/s43018-025-01034-w

Download citation

Published: 02 September 2025
DOI: https://doi.org/10.1038/s43018-025-01034-w

关于《Artificial intelligence for prostate cancer diagnostics》的评论

暂无评论

发表评论

摘要

MRI has become a crucial tool for enhancing the accuracy of prostate cancer diagnosis, but subjective assessment remains challenging. Recent research indicates that AI can assist in overcoming this issue by improving MRI-based predictions of prostate cancer aggressiveness.